Stockreport

TScan Therapeutics GAAP EPS of -$0.25, revenue of $1.04M Nov. 12, 2024 9:48 AM ET By: Urvi Shah , SA News Editor [Seeking Alpha]

TScan Therapeutics, Inc.  (TCRX) 
PDF TScan Therapeutics: Speculative Buy With Near-Term Catalysts In Oncology Seeking Alpha's Quant Rating on TScan Therapeutics Historical earnings data for TScan Thera [Read more]